EDC1 has been shown to cure Pancreatic Cancer in mice and safe in primates. EDC1 targets a metastatic cancer marker called dysadherin which is found on many untreatable cancers and surrounding stromal cells that protect and feed cancers. When EDC1 finds its target, it kills the entire tumor mass by a mechanism that affects the electrical potential of cells, making it impossible for them to grow and survive. The result leads to a death process known as necrosis, a natural mechanism evolved to remove unwanted cells and induce immune system activation.
EDC1